Connect Biopharma Holdings Limited - Ordinary Shares (CNTB) analyst actions
Rating and price-target actions on CNTB in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CNTB overview →
2 measured CNTB analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD | Press release | -2.53% | -2.53% | |
| Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma | Press release | +0.00% | -6.05% |
Keep exploring
More CNTB: earnings → · SEC filings → · CNTB overview →